Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Yellow fever virus envelope glycoprotein E (commonly referred to as the YFV E protein) is the principal surface protein of the yellow fever virus, a member of the Flaviviridae family. It plays a critical role in the viral life cycle by mediating host cell attachment and subsequent membrane fusion within the endosome, which are essential steps for viral entry and infection. Structurally, the E protein is organized as a homodimer on the virion surface and consists of three distinct domains (I, II, and III). Domain III contains the primary neutralizing epitopes that interact with host cell receptors and elicit strong protective immune responses, making it the major target of neutralizing antibodies during natural infection and vaccination. Although the live-attenuated yellow fever vaccine (17D) effectively targets this protein to provide lifelong immunity, there are currently no approved direct-acting small molecule antivirals that target the E protein. However, therapeutic monoclonal antibodies, such as TY014, have been developed and evaluated in clinical trials, demonstrating the ability to neutralize the virus and prevent viremia by blocking viral attachment and membrane fusion. Other monoclonal antibodies like MBL-YFV-01 and 5A are also being investigated as potential post-exposure therapies or prophylactics.
Inhibition of viral attachment to host cell receptors, blockade of viral membrane fusion by preventing E protein dimer-to-trimer transition, and neutralization of viral particles.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Yellow fever virus envelope glycoprotein E (YFV E).